| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals, Inc. (RYTM) has 15 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. RYTM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 111.9K | $11.35M | - | |
| Other | 25.5K | $2.58M | - | |
| CEO | 14.1K | $1.43M | - | |
| Other | 8.4K | $849.1K | - | |
| Dir | 7.0K | $713.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2017 | Meeker David P | Director | Buy | 25,000 | $17.00 | $425,000.00 | +32.8% | |
| Oct 10, 2017 | Pfizer Inc | 10% Owner | Buy | 40,000 | $17.00 | $680,000.00 | +2.9% | |
| Oct 10, 2017 | Ipsen, S.A. | 10% Owner | Buy | 20,000 | $17.00 | $340,000.00 | +2.5% | |
| Oct 10, 2017 | Orbimed Advisors LLC67 | 10% Owner | Buy | 355,000 | $17.00 | $6,035,000.00 | +13.9% | |
| Oct 10, 2017 | Sandell Scott D55 | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | |
| Oct 5, 2017 | Baker Bros. Advisors LP59 | Former 10% Owner | Buy | 885,000 | $17.00 | $15,045,000.00 | +76.0% |